Schedule of Deferred Assets (Details) - Eos SENOLYTIXS Inc [Member] - USD ($) |
Mar. 31, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Restructuring Cost and Reserve [Line Items] | ||
| Deferred asset acquisition costs | $ 384,288 | |
| Deferred financing costs | 30,154 | |
| Deferred assets | $ 414,442 |
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Net amount of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs or deferred acquisition costs of insurance companies. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|